6939
啟弘生技
-4.04%
(-0.04)
啟弘生技 (6939.TW) 2025Q4 financial report shows revenue of 106.16M TWD, with a YoY growth rate of 19.33%. This data clearly demonstrates significant revenue growth, with the company showing strong operational momentum and a marked increase in market demand. To fully capture future growth potential and investment opportunities, investors should closely monitor 啟弘生技 (6939.TW)’s upcoming financial reports and key strategic adjustments, and leverage diversified data analysis, especially advanced tools like Growin AI Value Analysis, for a comprehensive and forward-looking evaluation.